-
1 Comment
Acadia Healthcare Company, Inc is currently in a long term uptrend where the price is trading 18.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
Acadia Healthcare Company, Inc's total revenue sank by 135.4% to $-276M since the same quarter in the previous year.
Its net income has dropped by 6863.5% to $-784M since the same quarter in the previous year.
Finally, its free cash flow grew by 39.6% to $166M since the same quarter in the previous year.
Based on the above factors, Acadia Healthcare Company, Inc gets an overall score of 3/5.
Sector | Healthcare |
---|---|
Industry | Medical Care Facilities |
Exchange | NASDAQ |
CurrencyCode | USD |
ISIN | US00404A1097 |
Beta | 1.13 |
---|---|
Market Cap | 2B |
PE Ratio | 8.19 |
Target Price | 46.3846 |
Dividend Yield | None |
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ACHC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025